Shortage reports
Actual shortage:
69 (11%)
Anticipated shortage:
1 (0%)
Avoided shortage:
16 (2%)
Resolved:
563 (87%)
649
Discontinuation Reports
To be discontinued:
7 (10%)
Discontinued:
54 (75%)
Reversed:
11 (15%)
72
52 (7%)
17 (22%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-02-12 | 2024-04-04 | 219378 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-31 | 2024-01-30 | 200443 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2025-04-01 | 2025-06-14 | 253778 |
| GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-10-23 | 2024-04-04 | 207850 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-07-08 | 2021-02-10 | 119747 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-11-01 | 2026-01-06 | 241793 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-26 | 2024-05-29 | 223456 |
| GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2026-01-06 | 223453 |
| HYDROCHLOROTHIAZIDE | 50MG | TABLET | Actual shortage | 2024-06-06 | 2024-06-06 | 229804 |
| IMATINIB | 100MG | TABLET | Resolved | 2024-04-19 | 2025-11-04 | 225711 |
| IMATINIB | 400MG | TABLET | Resolved | 2024-04-19 | 2025-11-04 | 225714 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-10-01 | 2018-10-31 | 62786 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2018-10-01 | 2018-10-31 | 62789 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2023-06-27 | 2023-11-13 | 196716 |
| IRBESARTAN | 75MG | TABLET | Actual shortage | 2019-06-10 | 2024-11-25 | 86036 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2024-11-25 | 2025-12-09 | 243736 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2024-11-25 | 2025-12-09 | 243729 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2020-03-10 | 2021-07-08 | 108347 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108344 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-03-10 | 2021-02-10 | 108341 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAMIPRIL-HCTZ | 12.5MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3029 |
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3026 |
| RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| ROPINIROLE | 5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4945 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| SOLIFENACIN | 10MG | TABLET | Reversed | 2024-07-24 | 2025-01-13 | 233602 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| TRAMADOL/ACET | 325MG 37.5MG | TABLET | Discontinued | 2020-04-08 | 2020-07-07 | 111524 |